• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
The Egyptian Journal of Plastic and Reconstructive Surgery
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 49 (2025)
Volume Volume 48 (2024)
Volume Volume 47 (2023)
Volume Volume 46 (2022)
Volume Volume 45 (2021)
Volume Volume 44 (2020)
Volume Volume 43 (2019)
Issue Issue 3
Issue Issue 2
Issue Issue 1
Volume Volume 42 (2018)
Salama, S., Kamel, I., Ghanim, M., Elsherif, A. (2019). The Efficacy of Autologous Nebulized Platelet Rich Plasma (PRP) As an Early Adjuvant Therapeutic and Prognostic Treatment Modality in the Management of Inhalation Lung Injury. The Egyptian Journal of Plastic and Reconstructive Surgery, 43(2), 203-208. doi: 10.21608/ejprs.2019.65115
Shereine M Salama; Ibrahim H Kamel; Mohamed Ghanim; Ahmad F Elsherif. "The Efficacy of Autologous Nebulized Platelet Rich Plasma (PRP) As an Early Adjuvant Therapeutic and Prognostic Treatment Modality in the Management of Inhalation Lung Injury". The Egyptian Journal of Plastic and Reconstructive Surgery, 43, 2, 2019, 203-208. doi: 10.21608/ejprs.2019.65115
Salama, S., Kamel, I., Ghanim, M., Elsherif, A. (2019). 'The Efficacy of Autologous Nebulized Platelet Rich Plasma (PRP) As an Early Adjuvant Therapeutic and Prognostic Treatment Modality in the Management of Inhalation Lung Injury', The Egyptian Journal of Plastic and Reconstructive Surgery, 43(2), pp. 203-208. doi: 10.21608/ejprs.2019.65115
Salama, S., Kamel, I., Ghanim, M., Elsherif, A. The Efficacy of Autologous Nebulized Platelet Rich Plasma (PRP) As an Early Adjuvant Therapeutic and Prognostic Treatment Modality in the Management of Inhalation Lung Injury. The Egyptian Journal of Plastic and Reconstructive Surgery, 2019; 43(2): 203-208. doi: 10.21608/ejprs.2019.65115

The Efficacy of Autologous Nebulized Platelet Rich Plasma (PRP) As an Early Adjuvant Therapeutic and Prognostic Treatment Modality in the Management of Inhalation Lung Injury

Article 8, Volume 43, Issue 2, July 2019, Page 203-208  XML PDF (6.64 MB)
Document Type: Original Article
DOI: 10.21608/ejprs.2019.65115
View on SCiNiTO View on SCiNiTO
Authors
Shereine M Salama* ; Ibrahim H Kamel; Mohamed Ghanim; Ahmad F Elsherif
The Department of Plastic, Burns and Maxillofacial Surgery, Faculty of Medicine, Ain Shams University, Cairo, Egypt
Abstract
Background: Despite considerable advances in our knowledge
of the pathophysiology of inhalation injury, there are
few specific therapeutic options, and patient care is mainly
supportive. Platelets release growth factors and other immune
system components to start healing process. By using nebulized
Platelet Rich Plasma (PRP), platelets may reduce inflammation
and stimulates bronchial tree healing. However, there are no
clear data supporting or refuting the use of inhaled PRP in
inhalation injury.
Objective: To evaluate the role of nebulized autologous
Platelet Rich Plasma (PRP) in management of Smoke Inhalation
Injury (SII) as early adjuvant therapeutic and prognostic
modality.
Methods: This is prospective study that included 40
patients with burns 25-50% TBSA and have inhalation lung
injury. They were divided into 2 groups; 20 patients received
aerosolized particles of nebulized PRP beside regular regimen.
The other control group included 20 patients and received
regular treatment regimen only.
Results: There was a statistical significant difference
(p<0.01) of biologic changes in upper airway with smoke
injury in study group patients compared to control group
patients who received regular protocol measured at the same
follow-up time interval, relatively same TBSA and initial
bronchoscopy scoring. The mean extubation time was 7±1
days in study group compared to 14±1 days in control group.
Study group less showed shorter hospital stay and less mortality
rate.
Conclusion: The application of aerosolize the PRP solution
in the nebulizer with regular treatment protocol of inhalation
burn patients could be a beneficial therapeutic tool for regenerating
of post burn damaged tracheo-broncho-pulmonary
tree. Further studies on larger patient population with clinical
and pathological evidences are warranted
Keywords
Smoke inhalation injury – Respiratory management; – PRP inhalation
Main Subjects
Burns
References
W.R. Clark: Smoke inhalation; diagnosis and treatment,
World J. Surg., 16: 24, 1992.
2- E.C. Kimmel and K.R. Still: Acute lung injury, acute
respiratory distress syndrome and inhalation injury: An
overview, Drug Chem. Toxicol., 22: 91, 1999.
3- L.C. Cancio: Airway management and smoke inhalation
injury in the burn patient, Clin. Plast. Surg., 36: 555,
2009.
4- H. Yamamura, S. Kaga, K. Kaneda and Y. Mizobata: Chest
computed tomography performed on admission helps
predict the severity of smoke-inhalation injury, Crit. Care,
17: R95, 2013.
5- R.P. Mlcak, O.E. Suman and D.N. Herndon: Respiratory
management of inhalation injury, Burns, 33 (1): 2-13,
2007.
6- M.J. Mosier, T.N. Pham, D.R. Park, J. Simmons, M.B.
Klein and N.S. Gibran: Predictive value of bronchoscopy
in assessing the severity of inhalation injury, J. Burn Care
Res., 33 (1): 65-73, 2012.
7- J.M. Albright, C.S. Davis, M.D. Bird, L. Ramirez, H.
Kim, E.L. Burnham, et al.: The acute pulmonary inflammatory
response to the graded severity of smoke inhalation
injury, Crit. Care Med., 40 (4): 1113-21, 2012.
8- R.P. Mlcak, O.E. Suman and D.N. Herndon: Respiratory
management of inhalation injury, Burns, 33 (1): 2-13,
2007.
9- Albright J.M., Davis C.S., Bird M.D., Ramirez L., Kim
H., Burnham E.L., et al.: The acute pulmonary inflammatory
response to the graded severity of smoke inhalation
injury. Crit. Care Med., 40: 1113-21, 2012.
10- Challenges in Research on the Pathophysiology of Smoke
Inhalation Injury and Its Clinical Management Lancet.
October 01; 388 (10052): 1437-1446. doi:10.1016/S0140-
6736 (16)31458-1, 2016.
11- Platelet-rich plasma: A review of biology and applications
in plastic surgery. Eppley B.L., et al.: Plast. Reconstr.
Surg., 2006.
12- Klement G.L., Yip T.T., Cassiola F., Kikuchi L., Cervi
D., Podust V., Italiano J.E., Wheatley E., Abou-Slaybi A.,
Bender E., et al.: Platelets actively sequester angiogenesis
regulators. Blood, 113: 2835-2842, 2009.
13- Demidova-Rice T.N., Wolf L., Deckenback J., Hamblin
M.R. and Herman I.M.: Human platelet-rich plasma-and
extracellular matrix-derived peptides promote impaired
cutaneous wound healing in vivo. PLoS One, 7: e32146,
2012.
14- Mammoto T., Jiang A., Jiang E. and Mammoto A.: Platelet
rich plasma extract promotes angiogenesis through the
angiopoietin1-Tie2 pathway. Microvasc. Res., 89: 15-24,
2013.
15- Nebulizer Applies PRP Directly to Damaged Lungs NEWS
PROVIDED BY Dr. Prabhat. Soni. Jul. 13, 08: 40 ET,
2015.
16- Challenges in Research on the Pathophysiology of Smoke
Inhalation Injury and Its Clinical Management Lancet.
208 Vol. 43, No. 2 / The Efficacy of Autologous Nebulized PRP as an Early Adjuvant Therapeutic
October 01; 388 (10052): 1437-1446. Doi: 10.1016/S0140-
6736(16)31458-1, 2016.
17- Prockop L. and Chichkova R.: Carbon monoxide intoxication:
An updated review. J. Neurol. Sci., 262: 122-30.
[PubMed], 2007.
18- Yurt R.W., Bessey P.Q., Bauer G.J., et al.: A regional burn
center's response to a disaster: September 11, 2001, and
the days beyond. J. Burn Care Rehabil., 26 (2): 117-124.
[PubMed: 15756112], 2005.
19- Ihara K., Fujuda S., Enkhtaivan B., et al.: Abstract 19670:
Adipose-derived Mesenchymal Stem Cells Attenuate
Pulmonary MicrovascularHyperpermeability After Smoke
Inhalation. Circulation, 132 (Suppl 3): A19670, 2015.
20- Acceleration of Lung Regeneration by Platelet-Rich
Plasma Extract through the Low-Density Lipoprotein
Receptor-Related Protein 5-Tie2 Pathway Am. J. Respir.
Cell. Mol. Biol., Jan., 54 (1): 103-113, 2016

Statistics
Article View: 948
PDF Download: 2,030
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.